These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8578612)

  • 1. Functional relevance of dopamine receptors.
    Seabrook GR; Patel S; Hutson PH; Ragan CI; Bristow LJ
    Trends Pharmacol Sci; 1995 Dec; 16(12):406-8. PubMed ID: 8578612
    [No Abstract]   [Full Text] [Related]  

  • 2. Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?
    Routledge C; Thorn L; Ashmeade T; Taylor S
    Biochem Soc Trans; 1996 Feb; 24(1):199-201. PubMed ID: 8674661
    [No Abstract]   [Full Text] [Related]  

  • 3. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
    Kurashima M; Yamada K; Nagashima M; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
    Caine SB; Geyer MA; Swerdlow NR
    Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
    Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
    TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
    J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
    Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N
    Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
    Brudzynski SM; Komadoski M; St Pierre J
    Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
    Griffon N; Pilon C; Sautel F; Schwartz JC; Sokoloff P
    J Neural Transm (Vienna); 1996; 103(10):1163-75. PubMed ID: 9013403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional role of dopamine D3 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the development of dopamine D(3) receptor agonists and antagonists.
    Crider AM; Scheideler MA
    Mini Rev Med Chem; 2001 May; 1(1):89-99. PubMed ID: 12369994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of discrimination by agonists for D2 and D3 dopamine receptors.
    Burris KD; Pacheco MA; Filtz TM; Kung MP; Kung HF; Molinoff PB
    Neuropsychopharmacology; 1995 Jul; 12(4):335-45. PubMed ID: 7576010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of antipsychotic drugs]].
    Bourin M
    Encephale; 2006 Jan; 32 Pt 2():S8-9. PubMed ID: 16800078
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional models for the dopamine D3 receptor.
    Griffon N; Sautel F; Pilon C; Lévesque D; Sokoloff P; Schwartz JC; Diaz J; Simon P; Costentin J; Mann A; Wermuth CG
    Biochem Soc Trans; 1996 Feb; 24(1):193-8. PubMed ID: 8674660
    [No Abstract]   [Full Text] [Related]  

  • 17. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
    Piercey MF; Hyslop DK; Hoffmann WE
    Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of putative dopamine D3 receptor agonists, 7-OH-DPAT and quinpirole, on prolactin secretion in rats.
    Kurashima M; Domae M; Inoue T; Nagashima M; Yamada K; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1996 Feb; 53(2):379-83. PubMed ID: 8808147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of quinpirole by (+)-AJ 76: possible involvement of D3 receptors.
    Gui-Hua C; Woolverton WL
    Eur J Pharmacol; 1991 Dec; 209(3):285-6. PubMed ID: 1686769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.